Hasil Pencarian  ::  Simpan CSV :: Kembali

"Imaging is crucial in the multidisciplinary approach to head and neck cancer management. The rapid technological development of recent years makes it necessary for all members of the multidisciplinary team to understand the potential applications, limitations, and advantages of existing and evolving imaging technologies. It is equally important that the radiologist has sufficient clinical background knowledge to understand the clinical significance of imaging findings. This book provides an overview of the findings obtained using different imaging techniques during the evaluation of head and neck neoplasms, both before and after therapy. All anatomic areas in the head and neck are covered, and the impact of imaging on patient management is discussed in detail. The authors are recognized experts in the field, and numerous high-quality images are included. This second edition provides information on the latest imaging developments in this area, including the application of PET-CT and diffusion-weighted magnetic resonance imaging."

"As a result of the increasing number of surgical procedures on the brain, head, neck, and spine, postoperative changes are being encountered more frequently on neuroradiological examinations. However, these findings are often unfamiliar to neuroradiologists and neurosurgeons and can be difficult to interpret. This book, which contains numerous images and to-the-point case descriptions, is a comprehensive yet concise reference guide to postsurgical neuroradiology. It will enable the reader to identify the type of surgery performed and the hardware implanted and to differentiate expected sequelae from complications. Topics reviewed include trauma, tumors, vascular disorders, and infections of the head, neck, and spine; cerebrospinal fluid abnormalities; and degenerative diseases of the spine. This book will serve as a unique and convenient resource for both neuroradiologists and neurosurgeons."

"The book is divided into three parts: 1. Anatomy, which covers relevant sonographic anatomy in the head and neck (with complementary images from CT, MRI); 2. Diagnoses, the core content of the book with detailed sonographic description of common Head &​ Neck lesions, key clinical information and practical scanning tips towards identifying the wide spectrum of diseases in this region; 3. Differential Diagnoses, which provides differential diagnoses for common sonographic signs/​appearances. Although the book is on ultrasound, readers will find images from other imaging modalities so as to highlight the importance of multimodality imaging in modern clinical practice. This book is a compilation of Head and Neck sections of three previous books published by AMIRSYS, namely Diagnostic Imaging: Ultrasound; Diagnostic and Surgical Imaging Anatomy: Ultrasound and Expertddx: Ultrasound. The text &​ images (over 400) in the Anatomy section of the book remain relatively unchanged from the earlier book. In addition to the twenty diagnoses in the Diagnostic section of the earlier book, twenty one new diagnoses/​chapters have been added. This entire section of the book now contains over a thousand images (almost all of these are new images with comprehensive annotation), in particular, illustrative images of shear wave elastography &​ strain imaging have been included. The key facts box feature of the book remains in this section &​ is ideal for a quick review for readers with short attention spans. The Expertddx section of this book has over two hundred &​ fifty images (half of which are new) &​ includes key references"

"Anemia merupakan salah satu efek samping yang paling sering dialami pasien kanker yang diterapi dengan cisplatin dosis tinggi. Penelitian ini bertujuan untuk mengamati perkembangan anemia dan menentukan faktor-faktor yang berpengaruh terhadap anemia pada pasien yang diterapi cisplatin. Dilakukan pengumpulan data pada pasien kanker kepala dan leher yang menjalani kemoterapi berbasis cisplatin antara Desember 2002 hingga Desember 2005. Insidensi dan faktor risiko anemia dianalisis dengan mencakup faktor usia, jenis kelamin, kadar Hb awal, klirens kreatinin awal, dan metastasis jauh. Stratifikasi menurut usia dan jenis kelamin dilakukan terhadap kadar Hb awal dan CrCl awal. Analisis multivariat digunakan untuk mengidentifikasi prediktor independen anemia. Dari 86 pasien, 26 (30,2%) mengalami anemia, ditandai kadar hemoglobin < 11 g/dL. Kadar hemoglobin turun secara signifikan setelah siklus pertama, dan terus menurun. Usia > 55 tahun (RR = 2.2, 95% CI, 1.2-4.0), jenis kelamin perempuan (RR = 2.0, 95% CI, 1.2-3.8), kadar Hb awal ≤ 13 g/dL (RR = 4.2, 95% CI, 1.9-9.4) dan CrCl awal < 50 mL/menit (RR = 2.9, 95% CI, 1.7-5.1) berkorelasi dengan insidensi anemia (P < 0.05). Pada analisis multivariat, kadar hemoglobin awal dan klirens kreatinin awal merupakan faktor risiko independen anemia. Akan tetapi, terdapat efek perancu pada klirens kreatinin awal pada stratifikasi menurut usia (aRR = 2.2, 95% CI, 1.1-4.7). Kadar hemoglobin awal merupakan prediktor terkuat dari anemia. Kadar hemoglobin awal ≤ 13 g/dL ke bawah dan klirens kreatinin awal < 50 g/dL merupakan prediktor independen anemia akibat cisplatin, sehingga keduanya bernilai penting terhadap upaya prevensi anemia.

---

AbstractCisplatin is well-known for its effectiveness against cancer, as well as its toxicity to human tissues. Of several documented side effects, anemia was reported to have significant association with decreased quality of life. This study was conducted to investigate development of cisplatin-induced anemia, and to identify independent factors contributing to anemia. Clinical data from head and neck cancer patients treated with high-dose cisplatin between December 2002 and December 2005 were obtained in this study. Incidence and risk factors of anemia were assessed in a model including age, sex, baseline hemoglobin level, baseline creatinine clearance, and occurrence of distant metastases. Multivariate logistic regression was used to define independent predictors of anemia. Among 86 eligible patients, 26 (30.2%) developed anemia, defined as Hb level lower than 11 g/dL. Age > 55 years old (RR = 2.2, 95% CI, 1.2-4.0), female sex (RR = 2.0, 95% CI, 1.2-3.8), baseline Hb ≤ 13 g/dL (RR = 4.2, 95% CI, 1.9-9.4) and baseline CrCl < 50 mL/min (RR = 2.9, 95% CI, 1.7-5.1) were significantly correlated with incidence of anemia (P < 0.05). In multivariate analysis, baseline Hb and baseline CrCl were identified as independent risk factors for anemia. However, considerable confounding was observed in baseline CrCl after stratified by age (aRR = 2.2, 95% CI, 1.1-4.7). Thus, baseline Hb level was the strongest predictor of anemia. The findings suggested that baseline Hb and CrCl were useful to recognize cisplatin-treated patients at risk for anemia who might benefits from preventive measures."

"Gen P53 atau TP53 merupakan gen yang memicu pembentukan protein tumor p53 yang berfungsi sebagai tumor suppressor. Polimorfisme genetik p53 berpengaruh terhadap erjadinya kanker kepala dan leher (KKL). Penelitian ini bertujuan untuk mengidentifikasi keterkaitan antara polimorfisme gen p53 dengan kanker kepala dan leher di Indonesia. Analisis dengan PCR-RFLP (enzim BstUI) pada 50 sampel penderita KKL dan 50 sampel non KKL untuk melihat polimorfisme gen p53. Persentase distribusi genotip polimorfisme P53 pada sampel KKL sebesar 70% dan pada sampel non KKL sebesar 58%. Terdapat perbedaan bermakna pada distribusi genotip polimorfisme gen p53 antara penderita KKL dengan non KKL (p value = 0.004).

---

The gene P53 or TP53 is a gene that targets the formation of p53 tumor protein that functions as a tumor suppressor. Genetic polymorphism of p53 gene has been associated with the development of head and neck cancer. This study aims to identify the relationship between p53 gene polymorphism with head and neck cancer in Indonesia. Analysis with PCR-RFLP (BstUI enzyme) in 50 samples of head and neck cancer patients and 50 control samples to see p53 gene polymorphism. The percentage of polymorphic genotype in HNC samples is 70% and in non HNC is 58%. There are significant differences in the genotype distribution of p53 gene polymorphisms between HNC patients and non-HNC patients (p value = 0.004)."